February 8, 2025 - 14:37

The autonomy of the Morbidity and Mortality Weekly Report (MMWR), a key scientific journal published by the Centers for Disease Control and Prevention (CDC), has come under scrutiny as reports indicate increased influence from Trump administration officials. Health experts have expressed alarm over the erosion of the journal's independence, which has historically served as a critical platform for disseminating public health information and research findings.
One health official remarked, "The MMWR has lost its autonomy," highlighting a shift in how scientific data is being managed and reported. This change could potentially undermine the credibility of the journal, which has been a trusted source for health professionals and the public alike. Critics argue that political pressures may interfere with the integrity of the scientific process, raising questions about the reliability of the information being published.
As the MMWR continues to navigate these challenges, the implications for public health communication and policy remain significant, prompting calls for a reassessment of the relationship between science and politics.
May 13, 2026 - 19:53
From Zambia to Harvard: How Chimba Sanga Is Fighting HIV and TB With New SkillsChimba Sanga, a physician and public health leader from Zambia, is bringing his Harvard training back home to tackle two of the country`s deadliest diseases. Sanga, currently a Master of Public...
May 13, 2026 - 01:07
AP report: Marty Makary resigning as Trump's FDA chiefMarty Makary is resigning as head of the Food and Drug Administration, according to an Associated Press report. His departure comes after a turbulent tenure marked by deep internal discord and a...
May 12, 2026 - 10:26
Shortage of beds, staff force Michigan kids out of state for mental health treatmentMichigan children facing severe mental health crises are increasingly being transported out of state for treatment, sometimes traveling thousands of miles away from their families. The root cause...
May 11, 2026 - 17:47
Medicare’s miss on Alzheimer’s drug spendingFar fewer seniors than expected are taking costly Alzheimer`s drugs, leaving Medicare spending well below earlier government forecasts. The new class of amyloid-targeting treatments, including...